Related references
Note: Only part of the references are listed.Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
Gustavo Luna et al.
JAMA NEUROLOGY (2020)
The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients
Yan-Chao Li et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS
Yushun Wan et al.
JOURNAL OF VIROLOGY (2020)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms
Abdul Mannan Baig et al.
ACS CHEMICAL NEUROSCIENCE (2020)
SARS-CoV-2 Viral Load in Clinical Samples from Critically Ill Patients
Yongbo Huang et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19
Alfred H. J. Kim et al.
ANNALS OF INTERNAL MEDICINE (2020)
Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series
Xiao-Wei Xu et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Xueting Yao et al.
CLINICAL INFECTIOUS DISEASES (2020)
Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019
Xiaohua Chen et al.
CLINICAL INFECTIOUS DISEASES (2020)
Neurological manifestations in COVID-19 caused by SARS-CoV-2
Abdul Mannan Baig
CNS NEUROSCIENCE & THERAPEUTICS (2020)
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Zhe Xu et al.
LANCET RESPIRATORY MEDICINE (2020)
Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors
Melissa Bersanelli
IMMUNOTHERAPY (2020)
Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality
Chi Zhang et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Philippe Gautret et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
A first case of meningitis/encephalitis associated with SARS-Coronavirus-2
Takeshi Moriguchi et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: Imaging Features
Neo Poyiadji et al.
RADIOLOGY (2020)
Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia
Fan Wang et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Response to Comments on 'Zhang et al: Clinical trial analysis of 2019-nCoV therapy registered in China'
Qi Zhang et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Neurological manifestations associated with COVID-19: a review and a call for action
Matilde Leonardi et al.
JOURNAL OF NEUROLOGY (2020)
Multiple sclerosis and the risk of infection: considerations in the threat of the novel coronavirus, COVID-19/SARS-CoV-2
M. D. Willis et al.
JOURNAL OF NEUROLOGY (2020)
Sars-Cov-2: Underestimated damage to nervous system
Lingyan Zhou et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China
Ling Mao et al.
JAMA NEUROLOGY (2020)
The COVID-19 pandemic and the use of MS disease-modifying therapies
Gavin Giovannoni et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Coronavirus disease 2019 (COVID-19): a clinical update
Min Zhou et al.
FRONTIERS OF MEDICINE (2020)
Neurologists and COVID-19: A note on courage in a time of uncertainty
Renee A. Shellhaas
NEUROLOGY (2020)
Guillain-Barre Syndrome Associated with SARS-CoV-2
Gianpaolo Toscano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
Muthiah Vaduganathan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
Yan Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients
Amr H. Sawalha et al.
CLINICAL IMMUNOLOGY (2020)
Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review
V. Montalvan et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2020)
COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?
Giovanni Novi et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
An Italian programme for COVID-19 infection in multiple sclerosis
Maria Pia Sormani
LANCET NEUROLOGY (2020)
Coronavirus Disease-2019: Implication for the care and management of patients with systemic lupus erythematosus
Amr H. Sawalha et al.
EUROPEAN JOURNAL OF RHEUMATOLOGY (2020)
Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade
Chipman R. G. Stroud et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2019)
Guillain-Barre syndrome with unilateral peripheral facial and bulbar palsy in a child: A case report
Kamal Sharma et al.
SAGE OPEN MEDICAL CASE REPORTS (2019)
Human coronavirus circulation in the United States 2014-2017
Marie E. Killerby et al.
JOURNAL OF CLINICAL VIROLOGY (2018)
Axonal Transport Enables Neuron-to-Neuron Propagation of Human Coronavirus OC43
Mathieu Dube et al.
JOURNAL OF VIROLOGY (2018)
Cognition During and After Multiple Sclerosis Relapse as Assessed With the Brief International Cognitive Assessment for Multiple Sclerosis
Natasa Giedraitiene et al.
SCIENTIFIC REPORTS (2018)
Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors A Systematic Review and Meta-analysis
Daniel Y. Wang et al.
JAMA ONCOLOGY (2018)
A Systematic Assessment of Prevalence, Incidence and Regional Distribution of Multiple Sclerosis in Bavaria From 2006 to 2015
Tanja Daltrozzo et al.
FRONTIERS IN NEUROLOGY (2018)
Neurological Complications during Treatment of Middle East Respiratory Syndrome
Jee-Eun Kim et al.
JOURNAL OF CLINICAL NEUROLOGY (2017)
Viruses and Multiple Sclerosis: From Mechanisms and Pathways to Translational Research Opportunities
Alexios-Fotios A. Mentis et al.
MOLECULAR NEUROBIOLOGY (2017)
Comorbidity in multiple sclerosis is associated with diagnostic delays and increased mortality
Anja Thormann et al.
NEUROLOGY (2017)
Severe cytokine release syndrome in a patient receiving PD-1-directed therapy
Seth J. Rotz et al.
PEDIATRIC BLOOD & CANCER (2017)
Viruses and endogenous retroviruses in multiple sclerosis: From correlation to causation
A. -F. A. Mentis et al.
ACTA NEUROLOGICA SCANDINAVICA (2017)
Multiple sclerosis prevalence in the United States commercially insured population
Piyameth Dilokthornsakul et al.
NEUROLOGY (2016)
Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
Shuo Su et al.
TRENDS IN MICROBIOLOGY (2016)
A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview
Ruth Ann Marrie et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview
Ruth Ann Marrie et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Comorbidity increases the risk of hospitalizations in multiple sclerosis
Ruth Ann Marrie et al.
NEUROLOGY (2015)
Incidence and prevalence of multiple sclerosis in the UK 1990-2010: a descriptive study in the General Practice Research Database
I. S. Mackenzie et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Characterizing cognitive function during relapse in multiple sclerosis
Ralph H. B. Benedict et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Neurotropic virus tracing suggests a membranous-coating-mediated mechanism for transsynaptic communication
Yan-Chao Li et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2013)
Olfaction in Parkinson's disease and related disorders
Richard L. Doty
NEUROBIOLOGY OF DISEASE (2012)
The rising prevalence and changing age distribution of multiple sclerosis in Manitoba
R. A. Marrie et al.
NEUROLOGY (2010)
Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2
Jason Netland et al.
JOURNAL OF VIROLOGY (2008)
Imaging of acute disseminated encephalomyelitis
Andrea Rossi
NEUROIMAGING CLINICS OF NORTH AMERICA (2008)
Human coronavirus OC43 infection induces chronic encephalitis leading to disabilities in BALB/C mice
Helene Jacomy et al.
VIROLOGY (2006)
Age at disability milestones in multiple sclerosis
C Confavreux et al.
BRAIN (2006)
Trends in survival and cause of death in Danish patients with multiple sclerosis
H Bronnum-Hansen et al.
BRAIN (2004)
The vagus nerve is one route of transneural invasion for intranasally inoculated influenza A virus in mice
K Matsuda et al.
VETERINARY PATHOLOGY (2004)
Possible central nervous system infection by SARS coronavirus
KK Lau et al.
EMERGING INFECTIOUS DISEASES (2004)
Mortality from multiple sclerosis in Austria 1970-2001: dynamics, trends, and prospects
E Ekestern et al.
EUROPEAN JOURNAL OF NEUROLOGY (2004)
Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2
WH Li et al.
JOURNAL OF VIROLOGY (2004)
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
WH Li et al.
NATURE (2003)
Viral infections and antiphospholipid antibodies
IW Uthman et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2002)
Neuroinvasion by human respiratory coronaviruses
N Arbour et al.
JOURNAL OF VIROLOGY (2000)